Top Markets
#1 Siren Siren +34.00%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.80%
#3 Ribbita by Virtuals Ribbita by Virtuals +18.32%
#4 Cysic Cysic +17.30%
#5 Velvet Velvet +17.16%
#6 Wiki Cat Wiki Cat +17.08%
#7 PulseChain PulseChain +16.92%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.66%
#9 Perle Perle +14.95%
#10 KUB Coin KUB Coin +14.94%
Coin of the day
Siren Siren
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
BLIS Technologies Limited BLIS Technologies Limited

BLIS Technologies Limited

BLT
Classificação em ações #31230
BLIS Technologies Limited, together with its subsidiaries, specializes in... BLIS Technologies Limited, together with its subsidiaries, specializes in creating and distributing health-focused products. These offerings are underpinned by unique bacterial strains that exhibit bacteriocin activity. The company prominently features several key probiotic strains: BLIS K12, a supplement engineered to bolster ear, nose, and throat well-being in young children, in addition to enhancing immune function and combating halitosis; BLIS M18, an oral probiotic designed to promote robust dental and gum health; and BLIS Q24, a probiotic formulation aimed at harmonizing and rejuvenating the skin's microbiome, thereby fostering healthier, clearer, and more radiant skin. Established in 2000, BLIS Technologies is based in Dunedin, New Zealand, and maintains a global presence with operations spanning New Zealand, the Asia Pacific region, Europe, the Middle East, Africa, and North America.
Preço da ação
$0.01084256
Valor de mercado
$13.87M
Variação (1 dia)
0.00%
Variação (1 ano)
1.70%
País
NZ
Negociar BLIS Technologies Limited (BLT)

Categoria

Healthcare
Lucros da BLIS Technologies Limited (BLT)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da BLIS Technologies Limited, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da BLIS Technologies Limited de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE